NIAMS plans to fund resource-based centers that provide shared facilities and support for collaborative research on skin diseases, aiming to enhance and accelerate related scientific studies.
NIH will soon offer funding for research to develop non-addictive small molecule and biologic pain treatments, supporting projects from early optimization through Phase I trials as part of the HEAL Initiative.
This grant supports short-term exploratory clinical trials to improve prevention, diagnosis, or treatment of arthritis, musculoskeletal, or skin diseases through early-stage research.
This upcoming NIH grant will fund innovative preclinical research to develop new methods or agents that selectively target "undruggable" molecules involved in difficult-to-treat human diseases.
This grant funds clinical trials to advance prevention, treatment, or management of health issues caused by military-related toxic exposures, encouraging collaborative projects between clinicians and researchers.